Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo.

Wang, Hezhi; Ye, Xueshuai; Ju, Yi; Cai, Ziqi; Wang, Xiaoxiao; Du, Pingping; Zhang, Mengya; Li, Yang; Cai, Jianhui

Wang, Hezhi; Ye, Xueshuai; Ju, Yi; Cai, Ziqi; Wang, Xiaoxiao; Du, Pingping; Zhang, Mengya; Li, Yang; Cai, Jianhui.

Afiliação

Wang H; Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Ye X; Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Ju Y; Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People's Republic of China.
Cai Z; Department of Medicine, Medical College of Hebei University of Engineering, Handan, Hebei, People's Republic of China.
Wang X; Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People's Republic of China.
Du P; Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Zhang M; Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People's Republic of China.
Li Y; Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People's Republic of China.
Cai J; Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.

Onco Targets Ther ; 13: 3703-3716, 2020.

Article em En | MEDLINE | ID: mdl-32440140

Palavras-chave

cancer immunotherapy; cancer stem cell antigen; chimeric antigen receptor; nonviral vector; tumor suppression

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2020 Tipo de documento: Article